Literature DB >> 4037521

Causes of mortality in patients with the adult respiratory distress syndrome.

A B Montgomery, M A Stager, C J Carrico, L D Hudson.   

Abstract

This study analyzed the factors causing and contributing to death in patients with the adult respiratory distress syndrome (ARDS). Two hundred seven patients were prospectively identified as being at risk for development of ARDS. Forty-seven patients developed ARDS, and the remaining 160 patients were used as a comparison control group. The severity of dysfunction in 8 organ systems and the presence of sepsis syndrome were determined by chart review after discharge or death. Sepsis syndrome was specifically defined by signs and laboratory tests reflecting infection or inflammation plus evidence of a deleterious systemic effect (hypotension, reduced systemic vascular resistance, or unexplained metabolic acidosis). Mortality was 68% in the ARDS group compared to 34% in the control group (p less than 0.005). Only 16% (5 of 32) of deaths in the ARDS group were from irreversible respiratory failure. Most deaths in the first 3 days after entry into the study could be attributed to the underlying illness or injury. The majority of late deaths were related to sepsis syndrome. Of the 22 patients with ARDS who died after 3 days, 16 (73%) met our criteria for sepsis syndrome. There was a sixfold increase in sepsis syndrome after ARDS compared with that in the control group (p less than 0.001). When sepsis syndrome preceded the ARDS, the abdomen was the predominant source, but when sepsis syndrome occurred after the onset of ARDS there was usually a pulmonary source. Our findings indicate that sepsis syndrome, rather than respiratory failure, is the leading cause of death in patients with ARDS.

Entities:  

Mesh:

Year:  1985        PMID: 4037521     DOI: 10.1164/arrd.1985.132.3.485

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  153 in total

Review 1.  Ventilator-associated systemic inflammation in acute lung injury.

Authors:  C Putensen; H Wrigge
Journal:  Intensive Care Med       Date:  2000-10       Impact factor: 17.440

Review 2.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

Review 3.  Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium.

Authors:  Y Berthiaume; O Lesur; A Dagenais
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

4.  Successful treatment of acute respiratory distress syndrome after hysterectomy for life-threatening atonic bleeding by inhaled nitric oxide.

Authors:  Ayaka Fujita; Eiji Hashiba; Noriaki Otomo; Masatoshi Muraoka; Futoshi Kimura; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2011-06-03       Impact factor: 2.078

5.  Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor.

Authors:  M Kawasaki; K Kuwano; N Hagimoto; T Matsuba; R Kunitake; T Tanaka; T Maeyama; N Hara
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

6.  Adenoviral transfer of HSP-70 into pulmonary epithelium ameliorates experimental acute respiratory distress syndrome.

Authors:  Yoram G Weiss; Alina Maloyan; John Tazelaar; Nichelle Raj; Clifford S Deutschman
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 7.  The pulmonary physician and critical care. 2. The injured lung: conventional and novel respiratory therapy.

Authors:  A Swami; B F Keogh
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

Review 8.  The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.

Authors:  M Messent; M J Griffiths
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

9.  Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome.

Authors:  A R L Medford; L J Keen; J L Bidwell; A B Millar
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

10.  Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome.

Authors:  M N Gong; B T Thompson; P L Williams; W Zhou; M Z Wang; L Pothier; D C Christiani
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.